Arcoma AB

Stockholm Stock Exchange ARCOMA.ST

Arcoma AB Operating Cash Flow for the year ending December 31, 2023: USD 1.89 M

Arcoma AB Operating Cash Flow is USD 1.89 M for the year ending December 31, 2023, a 11,162.58% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Arcoma AB Operating Cash Flow for the year ending December 31, 2022 was USD -17.09 K, a 91.96% change year over year.
Arcoma AB Operating Cash Flow for the year ending December 31, 2021 was USD -212.71 K, a -125.64% change year over year.
Arcoma AB Operating Cash Flow for the year ending December 31, 2020 was USD 829.74 K, a -29.75% change year over year.
Arcoma AB Operating Cash Flow for the year ending December 31, 2019 was USD 1.18 M, a 23,229.19% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Stockholm Stock Exchange: ARCOMA.ST

Arcoma AB

CEO	Mr. Mattias Leire
IPO Date	Nov. 14, 2014
Location	Sweden
Headquarters	AnnavAegen 1
Employees	32
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in Växjö, Sweden.

Key trends

Past 5 years